Hasil Pencarian  ::  Simpan CSV :: Kembali

Abstrak :
Exceptional liver disease treatment starts with Biopsy Interpretation of the Liver. This book offers information on liver biopsy. It is suitable for physicians, surgeons, and clinicians.

Abstrak :
Latar belakang : Seiring dengan semakin efektifnya terapi Antiretroviral (ARV) pasien HIV memiliki harapan hidup lebih lama, morbiditas dan mortalitas penyakit HIV yang tidak berhubungan dengan Acquired Immunodeficiency Syndrome semakin meningkat. Non-alcoholic Fatty Liver Disease (NAFLD) telah dikenali sebagai penyakit hati tersering yang mempengaruhi lebih dari seperempat jumlah populasi global dan jumlahnya semakin meningkat di Indonesia. Pasien yang terinfeksi HIV memiliki risiko lebih tinggi untuk terkena NAFLD. Penelitian ini bertujuan untuk mendapatkan informasi tentang prevalensi dan faktor yang berhubungan dengan NAFLD pada pasien HIV dalam pengobatan antiretroviral (ARV) tanpa hepatitis viral kronis. Metode: Penelitian ini merupakan studi potong lintang yang melibatkan pasien HIV dalam pengobatan ARV tanpa koinfeksi virus hepatitis yang berobat di poliklinik Kelompok Studi Khusus (POKDISUS) Rumah Sakit Cipto Mangunkusumo Jakarta. NAFLD didefinisikan sebagai perlemakan di jaringan hati yang dibuktikan oleh pemeriksaan imaging transient elastography dengan Controlled Attenuation Parameter (CAP) setidaknya 238 dB/m. Perkiraan faktor-faktor yang berhubungan dengan NAFLD dianalisis dengan regresi logistik bivariat dan multivariat. Hasil: Pada penelitian ini secara keseluruhan didapatkan 105 subyek pasien HIV yang direkrut secara konsekutif. Prevalensi NAFLD didapatkan 52,4% (95% CI ±9,55). Faktor-faktor yang berhubungan dengan NAFLD pada populasi ini adalah hipertensi (PR = 3,755; 95% CI 1,218-11,575; p = 0,021) dan Index Massa Tubuh (IMT) (PR = 1,212 95% CI 1,051-1,396; p = 0,008). Faktor terkait HIV seperti CD4+ nadir, lama mendapat terapi ARV didapatkan tidak terkait NAFLD. Kesimpulan: Prevalensi NAFLD pada pasien HIV di Indonesia tinggi. NAFLD didapatkan berkaitan dengan hipertensi dan IMT, namun tidak dengan faktor-faktor terkait HIV. Penapisan non invasif untuk NAFLD sebaiknya diimplementasikan pada populasi ini untuk intervensi awal dan pencegahan komplikasi. ......Background: As HIV-infected persons experience longer life expectancies, other cause of morbidity and mortality among this group are increasingly being identified. Non-alcoholic fatty liver disease (NAFLD) has been recognized as the most common liver disease affecting more than a quarter of global population and increasing number in Indonesia. HIV-infected persons are at an increased risk of having NAFLD. This study aimed to inform prevalence and factors associated with NAFLD in HIV-infected patients without chronic viral hepatitis on antiretroviral therapy (ARV). Methods: A cross sectional study of HIV-infected person on ARV without hepatitis co-infection was done in HIV Integrated Clinic Cipto Mangunkusumo Hospital, Jakarta. NAFLD was defined as having at least 238 dB/m in transient elastography with associated Controlled Attenuation Parameter (CAP) examination. Bivariate and multivariate logistic regression analysis were applied to estimate factors associated with NAFLD Results: A total of 105 consecutive HIV infected person were included in the study analyzed. The prevalence of NAFLD was 52.4% (95% CI ±9.55). Factors related to NAFLD in this population were hypertension (PR = 3.755; 95% CI 1.218-11.575; p = 0.021) and Body Mass Index (BMI) (PR = 1.212 95% CI 1.051-1.396; p = 0.008). HIV specific variables such as nadir CD4, duration of ARV were not associated with NAFLD. Conclusion : There was a high prevalence of NAFLD among Indonesian person infected with HIV. NAFLD was associated with BMI and hypertension, but not with HIV related factors. Non-invasive screening for NAFLD should be implemented in this populaton to establish early intervention and prevent complication

Abstrak :
Latar belakang: Pilihan terapi terbaik untuk gagal hati terminal adalah transplantasi hati (TH). Setelah transplantasi seorang anak akan mempunyai hati dengan fungsi normal, namun tidak berarti menjadi anak yang sehat. Pasca TH anak akan berada dalam kondisi kronis dengan morbiditas tersendiri. Tujuan: Mengetahui perbedaan Quality of Life anak dengan penyakit hati kronis (PHK) yang dilakukan TH dengan yang tidak secara kuantitatif. Metode: Penelitian ini merupakan studi potong lintang terhadap anak pasca TH minimal selama 1 tahun dan anak PHK yang merupakan kandidat TH berusia 2-18 tahun. Subjek pasca TH diambil secara konsekutif, kelompok PHK minimal berjumlah setara dengan dengan kelompok pasca TH. Kedua kelompok dilakukan penilaian Quality of Life (QoL) menggunakan kuesioner PedsQLTM4.0 dalam Bahasa Indonesia yang telah divalidasi. Rerata nilai PedsQLTM4.0 pada anak sehat adalah 82,92+15,55 dan 83,91+12,47 masing-masing untuk proksi orangtua (OT) dan penilaian anak (A). Pada kondisi kronis rerata PedsQLTM,4.0 untuk proksi OT dan A masing-masing adalah 73,14+16,46 dan 74,16+15,38. Nilai yang lebih tinggi menunjukkan QoL yang lebih baik. Nilai <1 SD adalah batas anak memerlukan intervensi terkait QoL nya. Hasil: Kesintasan 1 dan 5 tahun pasca TH anak di RSCM adalah 85,4% dan 79,3%. Subjek pasca TH proporsi kelompok usia terbanyak adalah 5-7 tahun (66,7%), median usia 6 tahun 7,5 bulan; diagnosis dasar terbanyak adalah atresia bilier (84,6%). Pada subjek PHK kelompok usia terbanyak adalah 2-4 tahun (46,3%), median usia 9 tahun, penyebab terbanyak adalah kelainan vaskular (29,3%). Rerata total QoL subjek pasca TH 1 tahun lebih tinggi dibandingkan dengan subjek PHK. Kesimpulan: Rerata nilai total QoL 39 subjek pasca TH lebih baik dibandingkan 41 subjek PHK kandidat TH baik berdasarkan proksi OT maupun A secara bermakna. Penilaian QoL proksi OT dan anak menyimpulkan dimensi terbaik adalah fungsi sosial dan terendah fungsi sekolah. Pada penelitian ini QoL tidak dipengaruhi oleh status gizi, infeksi CMV/ EBV, ataupun rejeksi. ......Background: Liver transplantation (LT) is the best-known treatment for terminal chronic liver disease (CLD). Following a LT procedure, the patient will have a functional liver but is not considered as healthy child. Post LT, the patient will remain in a chronic condition with its own morbidity. Objective: To distinguish Quality of Life (QoL) distinction between terminal CLD patient who underwent LT and not. Methods: A cross-sectional study was conducted on 39 subjects consisting of 1 year LT survivor patient and 41 LT candidate children, aged 2-18 years. Liver recipient subjects were taken consecutively, equal amount CLD subjects were collected. Both groups were assessed for Quality of Life (QoL) using the validated PedsQLTM4.0 questionnaire in Indonesian. PedsQLTM4.0 cut-off point average scores in healthy children (population) are 82.92+15.55 and 83.91+12.47 each representing parent proxy (P) and child self-assessment (C). In chronic conditions children, cut off point average score of PedsQLTM4.0 for P and C were 73.14+16.46 and 74.16+15.38 respectively. Higher values ​​indicate better QoL. One standard deviation below the population mean was explored as a cut-off point score for an at-risk status of impaired QoL. Results: The 1 and 5 years-survival rate of LT children in RSCM were respectively 85.4% and 79.3%. Liver recipient subjects mostly consist of 5-7 years (66.7%) age group, median age was 6 years and 7.5 months; and the most prevalent diagnosis was biliary atresia (84.6%). In CLD, a portion of 2-4 years old age group (46.3%) was the dominant, the median was 9 years, and the most common diagnosis was vascular disorders (29.3%). Higher QoL score in post-transplant subjects was observed. Conclusion: LT children’s QoL was significantly higher than children who were candidate for LT, according to parent proxy and child self-assessment. Based on both parent proxy and child-assessment, social function was observed to have the best the QoL function and school function scored the lowest. In this study, QoL of liver recipient children were not affected by nutritional status, CMV or EBV infection, nor rejection.

Abstrak :
ABSTRAK
Aim: to know the effectiveness of probiotic in reducing hepatic inflammation among non-alcoholic fatty liver disease (NAFLD) patients. Methods: we performed literature searching regarding the potential role of probiotic in reducing hepatic inflammation among NAFLD patients. Results: six articles were finally critically appraised. All six studies had good validity and importance. These studies unanimously reported that probiotic is useful in reducing hepatic inflammation, and liver fat content. However, further evidence is needed to show whether or not probiotic is beneficial reducing cirrhosis progression and liver-related mortality. Conclusion: probiotic owns robust potential to treat NAFLD. Probiotic reduce hepatic inflammation, as shown by the reduction of liver aminotransferase, and inflammatory markers. Based on this evidence based report, probiotic is a promising adjunct therapy for NAFLD.

Abstrak :
Background: the risk of Non Alcoholic Fatty Liver Disease (NAFLD) is increasing in patients with type 2 diabetes. Prevalence and factors related to the increased risk of NAFLD in diabetic patients in Indonesia has never been studied before. Data regarding the profile of fibrosis in the population has also been unknown. This study aimed to identify the difference on the profile of diabetic patients with and without NAFLD as well as the degree of fibrosis. Methods: the study was conducted using a cross sectional method in type 2 diabetic patients who were treated at the outpatient clinic of endocrinology and metabolic division in Cipto Mangunkusumo Hospital. Sampling was done consecutively. Collected data comprised of age, duration of diabetes, body mass index (BMI), waist circumference, HDL, triglyceride, and HbA1C levels. Abdominal ultrasonography was conducted for all patients to determine the presence of NAFLD. Patients with NAFLD were subsequently underwent transient elastography in order to assess their degree of liver fibrosis. Chi-square or Fishers Exact tests were used for bivariate analysis and logistic regression was used for multivariate analysis. Results: as many as 186 patients were analyzed in the study and 84 patients (45.2%) were demonstrated to have NAFLD. Transient elastography examinations were carried out in 68 patients and 17 patients (25.0%) were found with severe fibrosis. Univariate analysis showed significant differences on BMI (PR=1.878; 95%CI= 1.296 2.721; p<0.001) and waist circumference (PR=2.368; 95%CI= 1.117 5.017; p=0.018) between patients with and without NAFLD. However, the multivariate test showed that BMI was the only factor that had a significance difference between both groups (OR=2.989; 95%CI=1.625-5.499; p<0.001). Conclusion: prevalence of NAFLD among type 2 diabetic patients in Cipto Mangunkusumo Hospital has reached 45.2% and 25.0% among them had severe fibrosis. BMI is the only factor found to be associated with the occurrence of NAFLD.

Abstrak :
ABSTRACT
Background: non alcoholic fatty liver disease (NAFLD) is known to be associated with some metabolic disorders. Recent studies suggested the role of uric acid in NAFLD through oxidative stress and inflammatory process. This study is aimed to evaluate the association between serum uric acid and NAFLD. Methods: a systematic literature review was conducted using Pubmed and Cochrane library. The quality of all studies was assessed using the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE). All data were analyzed using REVIEW MANAGER 5.3. Results: eleven studies from America and Asia involving 100,275 subjects were included. The pooled adjusted OR for NAFLD was 1.92 (95% CI: 1.66-2.23; p<0.00001). Subgroup analyses were done based on study design, gender, non-diabetic subjects, non-obese subjects. All subgroup analyses showed statistically significant adjusted OR and most of which having low to moderate heterogeneity. Two studies revealed relationship between increased serum uric acid levels and severity of NAFLD. No publication bias was observed. Conclusion: our study demonstrated association between serum uric acid level and NAFLD. This finding brings a new insight of uric acid in clinical practice. Increased in serum uric acid levels might serve as a trigger for physician to screen for NAFLD.

Abstrak :
ABSTRACT
Background: hypothyroidism is a common concomitant disease of non-alcoholic fatty liver disease (NAFLD). Previous studies regarding the relationship between subclinical hypothyroidism and NAFLD showed conflicting results, ranging from a strong association to not significant one. This case report aimed to investigate the risk of developing NAFLD in subclinical hypothyroidism patients. Methods: literature searching used ScienceDirect, PubMed, ProQuest, and Scopus. Filtering process of titles and abstracts by using inclusion and exclusion criteria yielded 4 eligible articles (1 systematic review, 1 prospective cohort, 1 retrospective cohort, and 1 case-control study) for answering the clinical question. Critical appraisal was conducted by using worksheets from Centre for Evidence-Based Medicine, University of Oxford. Results: the systematic review was considered invalid due to its less comprehensive search for relevant studies, inappropriate article selection to find a causal relationship between diseases, and statistical heterogeneity. The retrospective cohort was decided unimportant because it possessed a relative risk of 0.85 (95% confidence interval [CI], 0.72--1.00) which the upper limit of its CI included 1.00. The rest were valid and had important risk relative and odds ratio (1.27 [95% CI, 1.09--1.47], 3.41 [95% CI, 1.16--9.98]; respectively). The number needed to harm (5 - 17) indicated the clinically meaningful harm of the exposure since only a few patients with subclinical hypothyroidism is needed to obtain one additional NAFLD incidence. Those two articles were also suitable to be applied in our case. Conclusion: patients with subclinical hypothyroidism, compared to euthyroid patients, are at higher risk of developing NAFLD.

Abstrak :
Latar Belakang dan tujuan: Penyakit hati kronik pada pasien pediatrik merupakan salah satu masalah utama kesehatan pada populasi anak-anak dengan angka morbiditas dan mortalitas yang cukup tinggi. Penilaian derajat fibrosis hati diperlukan untuk menentukan tatalaksana yang sesuai, menentukan prognosis, dan tindak lanjut pasca pengobatan. Pemeriksaan USG elastografi acoustic radiation force impulse ARFI merupakan metode penilaian derajat fibrosis hati yang bersifat tidak invasif, mudah dan cepat dikerjakan. Penelitian ini bertujuan untuk mendapatkan nilai titik potong derajat fibrosis USG elastografi ARFI pada pasien pediatrik dengan penyakit hati kronik. Metode: Pasien pediatrik dengan penyakit hati kronik menjalani pemeriksaan USG elastografi ARFI. Didapatkan nilai shear wave velocity SWV dari pemeriksaan ARFI yang menunjukkan elastisitas jaringan hati pada 18 subjek dan dihubungkan dengan hasil biopsi hati METAVIR . Kurva receiver-operating characteristic ROC dilakukan untuk menentukan titik potong derajat fibrosis hati. Hasil: Rerata nilai median ARFI pada pasien pediatrik dengan penyakit hati kronik tanpa fibrosis hati 1,21 m/s; fibrosis ringan F1 1,13 m/s; fibrosis signifikan F2 ; fibrosis berat F3 2,76 m/s; dan sirosis F4 3,84 m/s. Kurva ROC menunjukkan titik potong ARFI pada 1,98 m/s memiliki sensitivitas 100 untuk mendeteksi derajat fibrosis ge;F3. Kesimpulan: USG elastografi ARFI merupakan metode yang dapat diandalkan, cepat, dan non invasif untuk menentukan derajat fibrosis berat dan sirosis pada pasien pediatrik. Hasil pemeriksaan ARFI dapat membantu klinisi dalam tindak lanjut pengobatan dan alternatif biopsi hati pada kondisi tertentu. ......Background and objectives: Chronic liver disease in pediatric patients is one of the major health problems with high rates of morbidity and mortality. Assessment of the degree of liver fibrosis is needed to determine appropriate management, determine prognosis, and post treatment follow up. Ultrasound acoustic radiation force impulse ARFI elastography examination is a non invasive, easily and rapidly performed liver fibrosis assessment method. The objective of this study was to obtain the cut off value of fibrosis degree with ARFI examination in pediatric patients with chronic liver disease. Methods: Pediatric patients with chronic liver disease underwent ARFI ultrasound measurements. Shear wave velocity SWV value obtained from ARFI examination showing elasticity of liver tissue in 18 subjects and associated with liver biopsy results METAVIR . The receiver operating characteristic ROC curve is performed to determine cut off value of degree of liver fibrosis. Results Mean of SWV value in pediatric patients with chronic liver disease without liver fibrosis 1.21 m s mild fibrosis F1 1.13 m s significant fibrosis F2 severe fibrosis F3 2.76 m s and cirrhosis F4 3.84 m s. The ROC curve shows the cut off at 1.98 m s yielded a 100 sensitivity to detect the degree of fibrosis ge F3. Conclusions USG elastographic ARFI is a reliable, rapid, and non invasive method for determining the degree of severe fibrosis and cirrhosis in pediatric patients. The results of the ARFI examination may assist the clinician in the follow up of treatment and alternatives of liver biopsy in certain condition.

Abstrak :
Latar Belakang : Disbiosis mikrobiota usus dianggap berperan pada progresifitas NAFLD. Penelitian mengenai mikrobiota usus pada pasien NAFLD masih sedikit dan menunjukkan hasil yang berbeda. Tujuan : Mengetahui profil mikrobiota usus pada pasien NAFLD dengan derajat fibrosis hati. Metode : Penelitian menggunakan desain potong lintang, dengan menggunakan sampel pasien NAFLD di Rumah Sakit Cipto Mangunkusumo, periode waktu Maret – Juli 2018. Pemeriksaan sampel feses secara konsekutif dilakukan dengan menggunakan alat isolasi DNA (Tiangen) dan quantitative real-time polymerase chain reaction (Fast 7500) untuk menghitung jumlah mikrobiota dinyatakan dalam copy number DNA/gram feses (Bacteroides, Lactobacillus and Bifidobacteria). Sedangkan pemeriksaan fibrosis hati dengan menggunakan alat transient elastography (FibroScan® 502 Touch). Analisis statistik dilakukan menggunakan analisis bivariat dengan menggunakan uji chi-square. Hasil : Dari 60 pasien NAFLD, didapatkan 35 pasien dengan fibrosis non signifikan dan 25 pasien dengan fibrosis signifikan. Kebanyakan pasien merupakan penderita diabetes melitus (85%), dislipidemia (58,3%), obesitas (58,3%), dan obesitas sentral (90%). Didapatkan jumlah Bacteroides (483.000 kopi unit DNA/gram feses) paling banyak dibandingkan dengan Lactobacillus (100.800 kopi unit DNA/gram feses) dan Bifidobacteria  (12.110 kopi unit DNA/gram feses). Dari ketiga mikrobiota tersebut terdapat peningkatan bermakna proporsi Bacteroides pada kelompok fibrosis signifikan (81%) dibandingkan dengan fibrosis non signifikan (19%). Begitupula dengan Lactobacillus yang jumlahnya lebih banyak pada fibrosis signifikan. Sedangkan pada Bifidobacteria, proporsi pada fibrosis signifikan lebih rendah dibandingkan fibrosis non signifikan. Simpulan : Terdapat perubahan komposisi mikrobiota usus pada pasien NAFLD. Proporsi Bacteroides juga meningkat pada kelompok fibrosis signifikan. ......Background: Dysbiosis of the gut microbiota has been considered to have a role in NAFLD progression. However, there is still lack of studies regarding this phenomenon. Aim of the study: To find the difference of gut microbiota profile in NAFLD patient based on the stages of liver fibrosis. Patients and Methods: A cross sectional study was conducted at Dr. Cipto Mangunkusumo Hospital which is the largest tertiary refferal center hepatobiliary outpatient’s clinic. Human fecal samples from NAFLD patients who came to outpatient clinic were collected consecutively. The stool sample examination was performed using isolation DNA kit (Tiangen) and quantitative real-time polymerase chain reaction (Fast 7500) was used to measure total bacterial counts (Bacteroides, Lactobacillus and Bifidobacteria). Clinical and laboratory data, Food Frequency Questionare (FFQ) were also collected. The stage of fibrosis were diagnosed based on transient elastography (FibroScan® 502 Touch). Statistical analysis including bivariate analysis were performed using SPSS version 20. Results: Of 60 human fecal samples, there are 35 patients had non significant fibrosis and 25 patients had significant fibrosis and consist of 46.7% male and 53.3% female with the median age is 56 years old. Most patient have diabetes (85%) dyslipidemia (58.3%), obesity (58.3%), and central obesity (90%).  The Bacteroides count (483000) was higher when compared to Lactobacillus (100800) and Bifidobacteria (12110). Of these three microbiota, the proportion of Bacteroides was higher in significant fibrosis group when compared to non significant fibrosis group. Patient with significant fibrosis was also has a higher proportion of Lactobacillus compared to non significant fibrosis group (7000 vs 2050). In contrast, the proportion of Bifidobacteria was lower in significant fibrosis group (22) when compared to non significant fibrosis group (95). Conclusion: There is a dysbiosis of gut microbiota in NAFLD patients. Bacteroides as a gram-negative microbiota that produces LPS is significantly increased with fibrosis stage, that may play a role in NAFLD progression.

Abstrak :
Latar Belakang Sirosis hepatis masih menjadi penyebab utama morbiditas dan mortalitas penyakit terkait hepar secara global. Selain itu, sirosis juga mengganggu kualitas hidup terkait kesehatan pasiennya. Penilaian kualitas hidup sering terlupakan dalam tatalaksana sirosis, padahal aspek ini lebih penting dibanding aspek luaran tradisional saja. Salah satu alat ukur kualitas hidup spesifik untuk pasien sirosis adalah Chronic Liver Disease Questionnaire (CLDQ). Meskipun alat ini sudah digunakan secara luas di negara lain, belum pernah ada penelitian yang menguji kesahihan dan keandalannya dalam Bahasa Indonesia. Penelitian ini bertujuan untuk menguji kesahihan dan keandalan CLDQ dalam Bahasa Indonesia dengan cara yang tepat. Metode Penelitian ini menggunakan desain potong lintang, dengan pengambilan sampel yang memenuhi kriteria bertempat di Poliklinik Hepatobilier RSCM dari April-Mei 2021. Penelitian diawali dengan menerjemahkan CLDQ ke dalam Bahasa Indonesia, kemudian diujicobakan (pretest) pada 10 orang responden, menghasilkan CLDQ dalam Bahasa Indonesia versi final yang digunakan pada penelitian utama dengan jumlah sampel yang lebih besar (52 orang responden). Uji kesahihan dilakukan dengan metode kesahihan konstruk dan eksternal, sementara uji keandalan dilakukan dengan metode konsistensi internal dan tes ulang. Hasil Penelitian ini menunjukkan bahwa kuesioner CLDQ dalam Bahasa Indonesia memiliki kesahihan konstruk yang baik dengan rentang r 0,613-0,917, kesahihan eksternal yang baik dengan 54,1% korelasi sedang dan kuat antara CLDQ dengan SF-36, keandalan konsistensi internal yang baik (Cronbach-Alpha ≥ 0.7), dan keandalan tes ulang yang juga baik (ICC > 0,7). Kesimpulan Kuesioner CLDQ dalam Bahasa Indonesia memiliki kesahihan dan keandalan yang baik untuk menilai kualitas hidup pasien sirosis hepatis di Indonesia. ......Background Liver cirrhosis still become the main cause of liver related morbidity and mortality around the world. Furthermore, cirrhosis also impairs health related quality of life. The evaluation in quality of life is sometimes forgotten in cirrhosis treatment, although this aspect is more important than traditional outcome. One of the specific tool to measure quality of life in cirrhosis patient is Chronic Liver Disease Questionnaire (CLDQ). Although this tool is widely used in many countries, there is still no research of validity and reliability in Indonesian language. This study purpose is to test the validity and reliability of CLDQ in Indonesian language with the correct methods. Methods This cross sectional study conducted the sampling location at Hepatobilliary outpatient clinic in RSCM, from April-May 2021. The study started by translating CLDQ into Indonesian language, and subsequently pretested in 10 people, resulting in final version of CLDQ in Indonesian language. The final version later tested in the main study with a bigger subjects (52 people). The validity test is conducted using construct and external methods, while the reliability test is conducted using internal consistency and test-retest methods. Results The Indonesian language CLDQ questionnaire has a good construct validity with r 0.613-0.917, good external validity with 54.1% moderate and strong correlations between CLDQ and SF-36, good internal consistency reliability (Cronbach-Alpha ≥ 0.7), and good test-retest reliability (ICC > 0.7). Conclusion The Indonesian language CLDQ questionnaire has a good validity and reliability to measure quality of life in liver cirrhosis patients in Indonesia.